Post
Fungal Disease Awareness Week: novel drugs essential to tackle antifungal resistance
18-22 September is Fungal Disease Awareness Week (FDAW) in the US, in which the Centers for Disease Control and Prevention …
Signal: UK NHS pay row intensifies as doctors launch joint strike
UK consultants and junior doctors walked out today (20 September) for joint strike action, the first in the National Health …
Medidata unveils new solution to boost clinical trial diversity
Medidata has unveiled a new solution called the Medidata Diversity Program, which aims to enhance diversity, equity, and inclusion in …
Taysha suspends its lead gene therapy programme after FDA feedback
Taysha Gene Therapies has discontinued its TSHA-120 development for gene therapy following a Type C meeting with the US Food …
1ST Biotherapeutics and Merck to assess cancer combination treatment
1ST Biotherapeutics has signed a clinical trial collaboration and supply agreement with Merck & Co (MSD) to assess FB849 plus Keytruda (pembrolizumab) …
Boundless Bio collaborates with Lilly for Phase I/II solid tumour trial
Boundless Bio has announced a collaboration with Eli Lilly for its first-in-human Phase I/II trial investigating BBI-355 in solid tumours. Under …
MRM Health reports data from ulcerative colitis therapy trial
Belgian biotechnology company MRM Health has reported positive topline data from the Phase IIa MH002-UC-201 clinical trial of MH002 for …
ImmPACT Bio begins dosing in Phase I/II lymphoma therapy trial
US-based biotechnology company ImmPACT Bio has dosed the first patient in its Phase I/II clinical trial of IMPT-314 for relapsed or …
Men from deprived areas in the UK benefit most from bowel screening programme
The Bowel Cancer Screening Programme (BCSP) was introduced in England in 2006 with the intention of lowering colorectal cancer (CRC) …
Caliway completes recruitment for second half of Phase II cellulite trial
Caliway Biopharmaceuticals has completed subject recruitment in a Phase II-stage 2 study investigating its candidate treatment for cellulite. The open-label trial, …
60 Degrees pauses Phase IIB Covid-19 trial for tafenoquine
60 Degrees Pharmaceuticals has withdrawn its investigational new drug (IND) application for ACLR8-LR, a Phase IIb study of the use …
Boundless Bio and Taiho to assess cancer combo therapy in Phase I/II trial
Boundless Bio has signed a clinical trial collaboration and supply agreement with Taiho Oncology to evaluate the combination of BBI-355 …
Rani Therapeutics initiates trial of RaniPill GO capsule
Rani Therapeutics has initiated a Phase I clinical trial of RT-111, a RaniPill GO capsule containing ustekinumab biosimilar CT-P43. The open-label, …
Iveric Bio reports positive data from GA therapy trial
Astellas company Iveric Bio has reported positive two-year-data from the Phase III GATHER2 clinical trial of IZERVAY (avacincaptad pegol intravitreal …
Aclaris unveils positive data from trial of ATI-2138
Aclaris Therapeutics has unveiled preliminary positive data from the Phase I multiple ascending dose (MAD) ATI-2138-PKPD-102 study evaluating the potential …